Author

M. Thomassen

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Interferon-α vs hydroxyurea in patients with myeloproliferative neoplasms (DALIAH): a multicentre, randomised, open-label, phase 3 trial in Denmark

DALIAH suggests that pegIFNα may offer long-term molecular benefit in selected patients highlighting the need for biomarkers that predict response and long-term tolerability.

T. Knudsen, D. Hansen, L. F. Ocias et al. · EClinicalMedicine · 0 citations

Sep 2026

Phenotypic manifestations and variant reclassification of germline PTEN variants: a nationwide Danish study.

The authors identified 87 different PTEN variants, and application of PTEN gene-specific ACMG guidelines led to reclassification of 32 variants, underscoring the importance of regular variant reassessment using the most recent gene-specific guidelines, ensuring optimal patient management and surveillance.

Annette Lyngholm Sandsdalen, A. M. Jelsig, B. Bertelsen et al. · Journal of Medical Genetics · 0 citations